General Information of Drug (ID: DMYN3IH)

Drug Name
AGI-1067 Drug Info
Synonyms AGZ-1067; Succinic acid 2,6-di-tert-butyl-4-[1-(3,5-di-tert-butyl-4-hydroxyphenylsulfanyl)-1-methylethylsulfanyl]phenyl monoester
Indication
Disease Entry ICD 11 Status REF
Artery stenosis BD52 Phase 3 [1]
Cross-matching ID
PubChem CID
216325
CAS Number
CAS 216167-82-7
TTD Drug ID
DMYN3IH

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Second phase insulin secretion (SPI secr) TT1AVS7 NOUNIPROTAC Inhibitor [2]

References

1 ClinicalTrials.gov (NCT00066898) ARISE Aggressive Reduction of Inflammation Stops Events. U.S. National Institutes of Health.
2 AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets. Mol Cell Endocrinol. 2010 Jul 29;323(2):246-55.